Clinical Intelligence
Point-of-care testing for the analysis of lipid panels: primary care diagnostic technology update
Annette Plüddemann, Matthew Thompson, Christopher P Price, Jane Wolstenholme and Carl Heneghan
British Journal of General Practice 2012; 62 (596): e224-e226. DOI: https://doi.org/10.3399/bjgp12X630241
Annette Plüddemann
Centre for Monitoring and Diagnosis, University of Oxford, Oxford
PhDRoles: director, Horizon Scanning Programme
Matthew Thompson
Centre for Monitoring and Diagnosis, University of Oxford, Oxford
DPhil, MRCGPRoles: GP, and senior clinical scientist
Christopher P Price
Centre for Monitoring and Diagnosis, University of Oxford, Oxford
PhD, FRCPathRoles: visiting professor in clinical biochemistry
Jane Wolstenholme
Centre for Monitoring and Diagnosis, University of Oxford, Oxford
BA, MSc, PhDRoles: health economics researcher
Carl Heneghan
Centre for Monitoring and Diagnosis, University of Oxford, Oxford
MA, MRCGP, DPhilRoles: clinical reader
Abstract
Clinical Question Does point-of-care testing (POCT) for lipids improve the risk stratification and management of cardiovascular disease compared to standard practice
- Received April 8, 2011.
- Accepted June 6, 2011.
- © British Journal of General Practice 2012
In this issue
Point-of-care testing for the analysis of lipid panels: primary care diagnostic technology update
Annette Plüddemann, Matthew Thompson, Christopher P Price, Jane Wolstenholme, Carl Heneghan
British Journal of General Practice 2012; 62 (596): e224-e226. DOI: 10.3399/bjgp12X630241
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals